Hydrochloric Acid → HCID 178495656, compound

HRID 2172487Notes

Reaction equation

HRID 2172487 reaction equation
[CH3:1][O:2][C:3]([NH:5][C@H:6]([C:11]([N:13]1[CH2:17][C@@H:16]([CH2:18][O:19][CH3:20])[CH2:15][C@H:14]1[C:21]1[NH:25][C:24]2[C:26]3[C:31]([CH:32]=[CH:33][C:23]=2[N:22]=1)=[CH:30][C:29]1[C:34]2[C:39]([CH2:40][O:41][C:28]=1[CH:27]=3)=[CH:38][C:37]([C:42]1[NH:46][C:45]([C@@H:47]3[CH2:51][CH2:50][CH2:49][N:48]3C(OC(C)(C)C)=O)=[N:44][CH:43]=1)=[CH:36][CH:35]=2)=[O:12])[C@@H:7]([CH3:10])[O:8][CH3:9])=[O:4].Cl.[CH3:60][O:61][C:62]([NH:64][C@H:65]([C:69]1[CH:74]=[CH:73][CH:72]=[CH:71][CH:70]=1)[C:66]([OH:68])=O)=[O:63].CCN(C(C)C)C(C)C.CCOC(C(C#N)=NOC(N1CCOCC1)=[N+](C)C)=O.F[P-](F)(F)(F)(F)F>C(Cl)Cl.CO.CN(C=O)C.[Li+].[OH-]>[CH3:1][O:2][C:3]([NH:5][C@@H:6]([CH:7]([O:8][CH3:9])[CH3:10])[C:11]([N:13]1[CH2:17][C@@H:16]([CH2:18][O:19][CH3:20])[CH2:15][C@H:14]1[C:21]1[NH:25][C:24]2[C:26]3[C:31]([CH:32]=[CH:33][C:23]=2[N:22]=1)=[CH:30][C:29]1[C:34]2[C:39]([CH2:40][O:41][C:28]=1[CH:27]=3)=[CH:38][C:37]([C:42]1[NH:46][C:45]([C@@H:47]3[CH2:51][CH2:50][CH2:49][N:48]3[C:66](=[O:68])[C@H:65]([NH:64][C:62](=[O:63])[O:61][CH3:60])[C:69]3[CH:74]=[CH:73][CH:72]=[CH:71][CH:70]=3)=[N:44][CH:43]=1)=[CH:36][CH:35]=2)=[O:12])=[O:4]

Participants

10

Reactant 5

HCID 313Hydrochloric AcidHCID 81531DiisopropylethylamineHCID 10910775(alphaR)-alpha-((Methoxycarbonyl)amino)benzeneacetic acidHCID 75951468(1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphateHCID 178495661tert-butyl (2S)-2-(5-{2-[(2S,4S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl}-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

Product 1

HCID 178495656HCID 178495656, compoundYield 61%

Reagents, catalysts & solvents 4

HCID 3939Lithium HydroxideCatalystHCID 887MethanolSolventHCID 6228DimethylformamideSolventHCID 6344DichloromethaneSolvent

Procedure

To a solution of tert-butyl (2S)-2-(5-{2-[(2S,4S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl}-1H-imidazol-2-yl)pyrrolidine-1-carboxylate (0.013 g, 0.016 mmol) in a mixture of CH2Cl2 (0.5 mL) and MeOH (0.02 mL) was added HCl (in dioxanes, 4M, 0.20 mL, 0.80 mmol). The solution was stirred at room temperature for 1 h, and then concentrated to dryness under reduced pressure. To the crude intermediate suspended in CH2Cl2 (0.5 mL) was added (R)-2-(methoxycarbonylamino)-2-phenylacetic acid (0.006 g, 0.029 mmol) and DIPEA (0.05 mL, 0.28 mmol). The resulting solution was cooled to 0° C. and COMU (0.012 g, 0.028 mmol) was added. The reaction was stirred at 0° C. for 30 min. The solution was diluted with DMF and aqueous LiOH (2.5 M, 2 drops) and concentrated under reduced pressure to remove the CH2Cl2. The crude residue was purified by preparative reverse phase HPLC (10% to 55% MeCN/water with 0.1% TFA). The desired fractions were combined and concentrated under reduced pressure to remove volatile organics. The addition of aqueous sodium bicarbonate with stirring resulted in precipitation of a white solid. The precipitate was filtered through a membrane filter and washed with water. Drying under reduced pressure afforded methyl {(1R)-2-[(2S)-2-(5-{2-[(2S,4S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methoxybutanoyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl}-1H-imidazol-2-yl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl}carbamate (0.008 g, 61%). 1H-NMR: 400 MHz, (MeOD) δ: (Mixture of rotamers) 8.37 (m, 1H), 7.96-7.98 (m, 2H), 7.60-7.79 (m, 3H), 7.35-7.52 (m, 6H), 6.98-7.03 (m, 1H), 5.52 (s, 1H), 5.26-5.39 (m, 2H), 5.20 (s, 2H), 4.44 (m, 1H), 4.27 (m, 1H), 3.64 (s, 6H), 3.50-3.57 (m, 3H), 3.37 (s, 3H), 3.29-3.44 (m, 3H), 3.20 (s, 3H), 2.68-2.72 (m, 2H), 2.57-2.62 (m, 2H), 1.89-2.15 (m, 6H), 1.18 (d, 3H).

Workup

  1. concentrationconcentrated to dryness under reduced pressure
  2. temperatureThe resulting solution was cooled to 0° C.
  3. stirringThe reaction was stirred at 0° C. for 30 min
  4. concentrationconcentrated under reduced pressure
  5. customto remove the CH2Cl2
  6. customThe crude residue was purified by preparative reverse phase HPLC (10% to 55% MeCN/water with 0.1% TFA)
  7. concentrationconcentrated under reduced pressure
  8. customto remove volatile organics
  9. additionThe addition of aqueous sodium bicarbonate
  10. stirringwith stirring
  11. customresulted in precipitation of a white solid
  12. filtrationThe precipitate was filtered through a membrane
  13. filtrationfilter
  14. washwashed with water
  15. customDrying under reduced pressure

Sources & evidence

ORD record
ord-45290c9f204a44b2af1ea263bef720e3
Source dataset
uspto-grants-2015_06
Patent number
US09051340B2

Reaction notes

Loading…